organization · Reporting owner
U S Venture Partners IX L P
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BOX INC
Report date June 02, 2017 · Filed June 08, 2017 · Amendment
Jointly reported with Presidio Management Group IX, L.L.C., FEDERMAN IRWIN, LIDDLE DAVID E, Matteucci Paul A, ROOT JONATHAN D, Tansey Casey M, YOUNG PHILIP M
Section 16 reporting ended · disclosed 2017-06-08. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectDirectly owned by USVP IX | 0 |
Last balance in matching sequence
After 2017-06-02 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-06-02 · Conversion · Acquired 8,000,000 · Balance 8,000,000 F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Row 2 · 2017-06-02 · Other · Disposed 8,000,000 · Balance 0 F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2: Prorata distribution in kind from the partnership without consideration to its limited partners. F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectDirectly owned by USVP IX | 3,713,775 |
Reported balance
After 2017-06-02 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2017-06-02 · Conversion · Disposed 8,000,000 · Balance 3,713,775 F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F2: Prorata distribution in kind from the partnership without consideration to its limited partners.
F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.
INTERMOLECULAR INC
Report date November 08, 2018 · Filed November 13, 2018
Jointly reported with Presidio Management Group IX, L.L.C., KRAUSZ STEVEN M, LIDDLE DAVID E, Matteucci Paul A, ROOT JONATHAN D, Tansey Casey M, YOUNG PHILIP M
Section 16 reporting ended · disclosed 2018-11-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by USVP IX | 0 |
Reported balance
After 2018-11-08 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-11-08 · Other · Disposed 4,280,779 · Balance 0 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | Direct | 856,155 |
Reported balance
After 2018-11-08 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2018-11-08 · Other · Acquired 856,155 · Balance 856,155 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-08 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2018-11-08 · Other · Disposed 856,155 · Balance 0 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by Steven Krausz | 97,593 |
Last balance in matching sequence
After 2018-11-13 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 4 · 2018-11-08 · Other · Acquired 102,093 · Balance 102,093 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Row 5 · 2018-11-12 · Sale · Disposed 2,100 · Balance 99,993 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Row 6 · 2018-11-13 · Sale · Disposed 2,400 · Balance 97,593 F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by David Liddle | 69,609 |
Reported balance
After 2018-11-08 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2018-11-08 · Other · Acquired 69,609 · Balance 69,609 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by Paul Matteucci | 60,408 |
Reported balance
After 2018-11-08 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2018-11-08 · Other · Acquired 60,408 · Balance 60,408 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by Jonathan Root | 85,851 |
Reported balance
After 2018-11-08 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2018-11-08 · Other · Acquired 85,851 · Balance 85,851 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by Casey Tansey | 60,336 |
Reported balance
After 2018-11-08 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2018-11-08 · Other · Acquired 60,336 · Balance 60,336 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common Stock, $0.001 per shareSEC Table I · non-derivative | IndirectDirectly owned by Philip Young | 82,370 |
Reported balance
After 2018-11-08 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2018-11-08 · Other · Acquired 82,370 · Balance 82,370 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.
F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Inspire Medical Systems, Inc.
Report date November 08, 2018 · Filed November 14, 2018
Jointly reported with Presidio Management Group IX, L.L.C., FEDERMAN IRWIN, KRAUSZ STEVEN M, LIDDLE DAVID E, Matteucci Paul A, ROOT JONATHAN D, YOUNG PHILIP M
Section 16 reporting ended · disclosed 2018-11-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by USVP IX | 1,084,127 |
Reported balance
After 2018-11-08 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-11-08 · Other · Disposed 1,084,127 · Balance 1,084,127 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 216,825 |
Reported balance
After 2018-11-08 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2018-11-08 · Other · Acquired 216,825 · Balance 216,825 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-08 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2018-11-08 · Other · Disposed 216,825 · Balance 0 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by Irwin Federman | 18,212 |
Reported balance
After 2018-11-08 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2018-11-08 · Other · Acquired 18,212 · Balance 18,212 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by Steven Krausz | 22,573 |
Reported balance
After 2018-11-08 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2018-11-08 · Other · Acquired 22,573 · Balance 22,573 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by David Liddle | 15,391 |
Reported balance
After 2018-11-08 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2018-11-08 · Other · Acquired 15,391 · Balance 15,391 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by Paul Matteucci | 13,356 |
Reported balance
After 2018-11-08 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2018-11-08 · Other · Acquired 13,356 · Balance 13,356 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by Jonathan Root | 18,982 |
Reported balance
After 2018-11-08 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2018-11-08 · Other · Acquired 18,982 · Balance 18,982 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectDirectly owned by Philip Young | 18,212 |
Reported balance
After 2018-11-08 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2018-11-08 · Other · Acquired 18,212 · Balance 18,212 F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.
F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 13, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | SaleCommon Stock, $0.001 per share | 2,400 | $0.95 | $2,280.00 |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 6 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Steven Krausz Disclosed balance after: 97,593 F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | SaleCommon Stock, $0.001 per share | 2,100 | $0.96 | $2,006.76 |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 5 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Steven Krausz Disclosed balance after: 99,993 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 18,212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 9 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Philip Young Disclosed balance after: 18,212 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 18,982 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 8 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Jonathan Root Disclosed balance after: 18,982 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 13,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 7 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Paul Matteucci Disclosed balance after: 13,356 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 15,391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 6 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by David Liddle Disclosed balance after: 15,391 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 22,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 5 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Steven Krausz Disclosed balance after: 22,573 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 18,212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 4 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Irwin Federman Disclosed balance after: 18,212 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 216,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 3 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 216,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 2 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,825 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. Read SEC document |
| November 08, 2018 Filed Nov 14, 2018 01:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | OtherCommon Stock | 1,084,127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 1 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by USVP IX Disclosed balance after: 1,084,127 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 82,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 11 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Philip Young Disclosed balance after: 82,370 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 60,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 10 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Casey Tansey Disclosed balance after: 60,336 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 85,851 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 9 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Jonathan Root Disclosed balance after: 85,851 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 60,408 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 8 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Paul Matteucci Disclosed balance after: 60,408 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 69,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 7 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by David Liddle Disclosed balance after: 69,609 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 102,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 4 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by Steven Krausz Disclosed balance after: 102,093 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 856,155 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 3 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 856,155 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 2 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 856,155 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 22:18 UTC | INTERMOLECULAR INC IMI · Entity 154785 | OtherCommon Stock, $0.001 per share | 4,280,779 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 1 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by USVP IX Disclosed balance after: 0 F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners. F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries F Convertible Preferred Stock · Derivative | 3,795,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 12 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 570,769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries E Convertible Preferred Stock · Derivative | 948,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 11 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 163,962 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F3 · derivative.exercise_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F3 · derivative.expiration_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries D Convertible Preferred Stock · Derivative | 1,397,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 10 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 210,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries C Convertible Preferred Stock · Derivative | 3,142,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 9 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 472,581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries B Convertible Preferred Stock · Derivative | 2,102,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 8 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 389,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F2 · derivative.exercise_date: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F2 · derivative.expiration_date: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionSeries A Convertible Preferred Stock · Derivative | 2,400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · derivative · entry 7 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 360,902 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 570,769 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 6 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,168,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 163,962 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 5 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,597,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 210,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 4 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,433,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 472,581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 3 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,223,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 389,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 2 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 750,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| May 07, 2018 Filed May 10, 2018 01:19 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | ConversionCommon Stock | 360,902 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 1 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner KRAUSZ STEVEN M · CIK 0001190636 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 360,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date. F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment | BOX INC BOX · Entity 3932 | ConversionClass B Common Stock · Derivative | 8,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001548538-17-000015 · edgar.xml · derivative · entry 3 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by USVP IX Disclosed balance after: 3,713,775 Underlying: Class A Common Stock · 8,000,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · derivative.underlying_shares: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment | BOX INC BOX · Entity 3932 | OtherClass A Common Stock | 8,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-17-000015 · edgar.xml · nonDerivative · entry 2 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by USVP IX Disclosed balance after: 0 F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F2 · kind: Prorata distribution in kind from the partnership without consideration to its limited partners. F2 · price: Prorata distribution in kind from the partnership without consideration to its limited partners. F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
| June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment | BOX INC BOX · Entity 3932 | ConversionClass A Common Stock | 8,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001548538-17-000015 · edgar.xml · nonDerivative · entry 1 Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner U S Venture Partners IX L P · CIK 0001309185 · 10% owner FEDERMAN IRWIN · CIK 0001192391 · 10% owner LIDDLE DAVID E · CIK 0001212726 · 10% owner Matteucci Paul A · CIK 0001370817 · 10% owner ROOT JONATHAN D · CIK 0001225480 · 10% owner Tansey Casey M · CIK 0001474322 · 10% owner YOUNG PHILIP M · CIK 0001048637 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Directly owned by USVP IX Disclosed balance after: 8,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.